Inventor · disambiguated record
Fanghong Li
Also filed as: LI FANGHONG
9 granted patents·4 pending applications·5 citations·filing 2014–2020
77Inventor score
Files withGUANGZHOU SINOGEN PHARMACEUTICAL CO LTD5NANJING SINOGEN BIOTECH & PHARMACEUTICAL INC4GUANGZHOU HUAZHEN PHARMACEUTICAL CO LTD2GUANGZHOU SINOGEN BIOMEDICAL TECH LTD2
Top patents by PatentIndex Score
13 records- 0176US9816083B2Genetically engineered bacterium for treatment of breast cancer, method for constructing the bacterium, and applications thereofNANJING SINOGEN BIOTECH & PHARMACEUTICAL INC·Filed 2014·Granted Nov 14, 2017·3 cites·4 claims
- 0276US9439934B1Application of an attenuated salmonella typhimurium, its genetically engineered bacterium in preparing drugs for the treatment of prostate cancerNANJING SINOGEN BIOTECH & PHARMACEUTICAL INC·Filed 2015·Granted Sep 13, 2016·2 cites·5 claims
- 0361US11318172B2Use of genetically engineered bacterium of attenuated Salmonella typhimurium in for treating liver cancerGUANGZHOU SINOGEN PHARMACEUTICAL CO LTD·Filed 2020·Granted May 3, 2022·0 cites·5 claims
- 0453US11771721B2Applications of genetically engineered bacteria VNP20009-M in preparation of drugs for preventing and treating lung cancerGUANGZHOU SINOGEN PHARMACEUTICAL CO LTD·Filed 2018·Granted Oct 3, 2023·0 cites·11 claims
- 0547US2023250451A1Application of methioninase gene therapy in treatment of malignant tumorGUANGZHOU SINOGEN PHARMACEUTICAL CO LTD·Filed 2020·Application pending·0 cites
- 0646US12478664B2Use of genetically engineered strain VNP20009-M in preventing and treating cancer metastasisGUANGZHOU SINOGEN PHARMACEUTICAL CO LTD·Filed 2017·Granted Nov 25, 2025·0 cites·6 claims
- 0744US11324781B2Application of genetically engineered bacteria VNP20009-M in preparing drug for treating malignant sarcomaGUANGZHOU SINOGEN PHARMACEUTICAL CO LTD·Filed 2018·Granted May 10, 2022·0 cites·14 claims
- 0843US10959977B2Application of phosphodiesterase 4 inhibitor ZL-n-91 in preparation of medications for lung cancer proliferation and metastasisGUANGZHOU SINOGEN BIOMEDICAL TECH LTD·Filed 2017·Granted Mar 30, 2021·0 cites·5 claims
- 0940US10113184B2Microbe transformant for weight loss and lipid reduction, the method for constructing the transformant, and application thereofNANJING SINOGEN BIOTECH & PHARMACEUTICAL INC·Filed 2016·Granted Oct 30, 2018·0 cites·5 claims
- 1038US2018339032A1Application of genetically genineered bacterium of attenuated salmonella typhimurium in preparation of medicine for treatment of liver cancerNANJING SINOGEN BIOTECH & PHARMACEUTICAL INC·Filed 2016·Application pending·0 cites
- 1136US12441732B2Potassium salt crystal form B of phosphodiesterase type 5 inhibitor, and preparation method and use thereforGUANGZHOU HUAZHEN PHARMACEUTICAL CO LTD·Filed 2020·Granted Oct 14, 2025·0 cites·19 claims
- 1231US2021269824A1Viral vector for treating autoimmune disease and diabetes and construction method and application thereofGUANGZHOU HUAZHEN PHARMACEUTICAL CO LTD·Filed 2018·Application pending·0 cites
- 1327US2019160036A1Application of phosphodiesterase 4 inhibitor zl-n-91 in preparation of medicament for treating prostate cancer proliferation and metastasisGUANGZHOU SINOGEN BIOMEDICAL TECH LTD·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Fanghong Li files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →